Affordable Access

Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's disease.

Authors
Type
Published Article
Journal
British journal of clinical pharmacology
Publication Date
Volume
64
Issue
1
Pages
36–48
Identifiers
PMID: 17324246
Source
Medline
License
Unknown

Abstract

A descriptive, robust and predictive model for NS2330 and its M1 metabolite was developed. Important covariates influencing pharmacokinetics were identified, which might guide the further development of NS2330 and optimize its long-term use in the treatment of Alzheimer's disease.

Statistics

Seen <100 times